Fundamental analysis by کدال۳۶۰ about Stock دلقما on 7/10/2024

#Dalqma #monthly_activity report #1 month period ending on 12/29/1402 (correction) of #Laqman Pharmaceutical and Health Company ▪️ Luqman Pharmaceutical and Health Company has sold its products in the amount of 261,322 million Rials during the performance of 1 month ending on 12/29/1402, which has decreased by 34% compared to the same period last year. ▪️ With a registered capital of 6,735,150 million Rials, during the 12-month performance of the financial year ending on 12/29/1402, Dalqma had a sales income of 9,836,043 million Rials, which has grown by 30% compared to the same period of the previous year. 04-20-1403 19:56:41 (1217385) ➖➖➖➖⬇️⬇️⬇️⬇️ @codal360_ir